CPT® Code 81504

1. Indications

The microarray gene expression profiling test (CPT® Code 81504) is indicated for use in various clinical scenarios related to oncology. The following conditions and symptoms may warrant the use of this procedure:

• Tumor Classification This test is utilized to accurately classify tumors based on their gene expression profiles, which can aid in determining the specific type of cancer present.
• Clinical Outcome Prediction The profiling provides insights into the likely clinical outcomes for patients, helping to inform treatment decisions and prognostic assessments.
• Assessment of Tumor Similarity The procedure is indicated for evaluating the similarity of a patient's tumor to a database of known tumor samples, which can assist in understanding the tumor's behavior and potential response to therapies.

2. Procedure

The procedure for microarray gene expression profiling involves several critical steps that ensure accurate results. Each step is essential for the successful execution of the test:

• Step 1: Sample Preparation The process begins with the collection of a tissue sample, which is then fixed in formalin and embedded in paraffin. This preservation method allows for the long-term storage of the tissue while maintaining its structural integrity for analysis.
• Step 2: RNA Extraction Once the tissue sample is prepared, the next step involves extracting messenger RNA (mRNA) from the tissue. This is achieved through a series of chemical processes that isolate the mRNA, which is crucial for the subsequent hybridization step.
• Step 3: Labeling of mRNA The extracted mRNA is then labeled with a fluorophore, a fluorescent dye that enables the detection of the mRNA during the scanning process. This labeling is essential for visualizing the gene expression levels on the gene chip.
• Step 4: Hybridization The labeled mRNA is hybridized to the complementary DNA (cDNA) sequences that are pre-attached to the gene chip. This step allows the mRNA to bind to specific probes on the chip, forming hybridization complexes that represent the gene expression profile of the tissue sample.
• Step 5: Scanning and Data Acquisition After hybridization, the gene chip is scanned using specialized equipment that detects the fluorescent signals emitted from the hybridized spots. The intensity of the fluorescence at each spot correlates with the expression level of the corresponding gene.
• Step 6: Data Analysis The collected data is then analyzed using computer software that applies algorithms to compare the gene expression patterns of the patient's sample against a database of tumor samples. This analysis results in tissue similarity scores that provide valuable insights into the tumor's characteristics.

3. Post-Procedure

After the microarray gene expression profiling procedure is completed, the results are compiled and interpreted by healthcare professionals. The expected outcomes include detailed reports that outline the gene expression patterns and tissue similarity scores. These results are crucial for oncologists in making informed decisions regarding diagnosis, treatment options, and prognostic evaluations. Additionally, it is important for healthcare providers to discuss the findings with the patient, addressing any questions or concerns regarding the implications of the results on their treatment plan. Follow-up care may involve further diagnostic testing or monitoring based on the insights gained from the profiling.